Literature DB >> 28442834

Parathyroidectomy Decreases Insulin Resistance Index in Patients with Primary Hyperparathyroidism.

Cevdet Duran1, Barıs Sevinc2, Orkide Kutlu1, Omer Karahan2.   

Abstract

Primary hyperparathyroidism (PHPT) has been considered a cause of insulin resistance (IR) and impaired glucose metabolism. However, there are conflicting results related with the recovery of insulin resistance in patients with PHPT following curative parathyroidectomy. Our aim is to evaluate the effects of curative parathyroidectomy on IR in patients with PHPT. This is a prospective interventional study. Twenty-one consecutive patients with symptomatic PHPT were included into the study. All patients underwent parathyroidectomy. Fasting serum glucose, calcium, phosphorous, parathormone, plasma insulin, and vitamin D levels were measured both at baseline and 2 months after parathyroidectomy. Insulin resistance was calculated by homeostasis of model assessment-insulin resistance (HOMA-IR). Two months after curative parathyroidectomy, serum levels of calcium (p = 0.001), PTH (p < 0.001), insulin (p = 0.003), and HOMA-IR (p = 0.003) decreased, while phosphorous levels increased (p = 0.001). During this period, no changes were observed at vitamin D and glucose levels. We concluded that curative parathyroidectomy decreases HOMA-IR index in patients with PHPT. Studies with larger population and longer follow-up period are required to confirm our results.

Entities:  

Keywords:  Homeostasis of model assessment-insulin resistance; Insulin resistance; Parathyroidectomy; Primary hyperparathyroidism

Year:  2016        PMID: 28442834      PMCID: PMC5386933          DOI: 10.1007/s12262-015-1431-4

Source DB:  PubMed          Journal:  Indian J Surg        ISSN: 0973-9793            Impact factor:   0.656


  28 in total

1.  Changes in insulin sensitivity and glucose and bone metabolism over time in patients with asymptomatic primary hyperparathyroidism.

Authors:  Semra Ayturk; Alptekin Gursoy; Neslihan Bascil Tutuncu; Derun Taner Ertugrul; Nilgun Guvener Demirag
Journal:  J Clin Endocrinol Metab       Date:  2006-08-08       Impact factor: 5.958

2.  Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the third international workshop.

Authors:  John P Bilezikian; Aliya A Khan; John T Potts
Journal:  J Clin Endocrinol Metab       Date:  2009-02       Impact factor: 5.958

3.  The important players in primary hyperparathyroidism.

Authors:  Jens Bollerslev
Journal:  Clin Endocrinol (Oxf)       Date:  2013-08-09       Impact factor: 3.478

4.  Factors influencing insulin sensitivity in patients with mild primary hyperparathyroidism before and after parathyroidectomy.

Authors:  Erik G Almqvist; Anne-Greth Bondeson; Lennart Bondeson; Dan Mellström; Johan Svensson
Journal:  Scand J Clin Lab Invest       Date:  2011-11-22       Impact factor: 1.713

Review 5.  Coincident diabetes mellitus and primary hyperparathyroidism.

Authors:  W H Taylor; A A Khaleeli
Journal:  Diabetes Metab Res Rev       Date:  2001 May-Jun       Impact factor: 4.876

6.  Plasma calcium as a predictor of cardiovascular disease in a community-based cohort.

Authors:  John P Walsh; Mark L Divitini; Matthew W Knuiman
Journal:  Clin Endocrinol (Oxf)       Date:  2013-04-13       Impact factor: 3.478

7.  Impaired glucose tolerance and insulin insensitivity in primary hyperparathyroidism.

Authors:  S Kumar; A O Olukoga; C Gordon; E B Mawer; M France; J P Hosker; M Davies; A J Boulton
Journal:  Clin Endocrinol (Oxf)       Date:  1994-01       Impact factor: 3.478

8.  Effect of surgery on cardiovascular risk factors in mild primary hyperparathyroidism.

Authors:  Jens Bollerslev; Thord Rosen; Charlotte L Mollerup; Jörgen Nordenström; Marek Baranowski; Celina Franco; Ylva Pernow; Gunhild A Isaksen; Kristin Godang; Thor Ueland; Svante Jansson
Journal:  J Clin Endocrinol Metab       Date:  2009-04-07       Impact factor: 5.958

9.  Insulin secretion, insulin sensitivity and hepatic insulin extraction in primary hyperparathyroidism before and after surgery.

Authors:  A Kautzky-Willer; G Pacini; B Niederle; G Schernthaner; R Prager
Journal:  Clin Endocrinol (Oxf)       Date:  1992-08       Impact factor: 3.478

10.  The relationship between primary hyperparathyroidism and diabetes mellitus.

Authors:  M P Bannon; J A van Heerden; P J Palumbo; D M Ilstrup
Journal:  Ann Surg       Date:  1988-04       Impact factor: 12.969

View more
  4 in total

Review 1.  The role of an anti-diabetic drug metformin in the treatment of endocrine tumors.

Authors:  Shilpa Thakur; Brianna Daley; Joanna Klubo-Gwiezdzinska
Journal:  J Mol Endocrinol       Date:  2019-08       Impact factor: 5.098

Review 2.  Diabetes and Bone Involvement in Primary Hyperparathyroidism: Literature Review and Our Personal Experience.

Authors:  Elena Castellano; Roberto Attanasio; Alberto Boriano; Valentina Borretta; Francesco Tassone; Giorgio Borretta
Journal:  Front Endocrinol (Lausanne)       Date:  2021-04-19       Impact factor: 5.555

3.  Effect of Parathyroidectomy on Metabolic Homeostasis in Primary Hyperparathyroidism.

Authors:  Samuel Frey; Raphaël Bourgade; Cédric Le May; Mikaël Croyal; Edith Bigot-Corbel; Nelly Renaud-Moreau; Matthieu Wargny; Cécile Caillard; Eric Mirallié; Bertrand Cariou; Claire Blanchard
Journal:  J Clin Med       Date:  2022-03-02       Impact factor: 4.241

4.  Assessment of insulin resistance in patients with primary hyperparathyroidism before and after Parathyroidectomy.

Authors:  Soudabeh Nikooei Noghani; Nasrin Milani; Mozhgan Afkhamizadeh; Mona Kabiri; Shokoufeh Bonakdaran; Leila Vazifeh-Mostaan; Mahdi Asadi; Negar Morovatdar; Masoud Mohebbi
Journal:  Endocrinol Diabetes Metab       Date:  2021-08-05
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.